Showing results (371-380 of 385) with videos related to
Sort By:
Pageof 39
Journal of Neurology|March 10, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMSTommaso Guerra, Giuseppe Lucisano, Maria A Rocca, et al.CNS Drugs|January 28, 2026
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter StudyGianmarco Abbadessa, Damiano Marastoni, Floriana Bile, et al.Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 20, 2022
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control StudyPietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2026
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)Damiano Paolicelli, Giuseppe Lucisano, Alessia Manni, et al.Journal of Neurology|April 2, 2024
The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sexNaila Makhani, Christine Lebrun-Frenay, Aksel Siva, et al.Journal of Neurology|April 3, 2024
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosisElisabetta Maida, Marcello Moccia, Raffaele Palladino, et al.Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2023
Sars-CoV2 infection in pregnant women with multiple sclerosisMaria Grazia Aprea, Irene Schiavetti, Emilio Portaccio, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2022
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosisDoriana Landi, Francesca Bovis, Alfonso Grimaldi, et al.Pageof 39